Shares of Neovasc Inc. (TSE:NVC – Get Free Report) (NASDAQ:NVCN) rose 2.3% during mid-day trading on Monday . The company traded as high as C$1.82 and last traded at C$1.78. Approximately 46,869 shares were traded during trading, a decline of 58% from the average daily volume of 111,876 shares. The stock had previously closed at C$1.74.
Neovasc Price Performance
The firm has a 50 day simple moving average of C$1.78.
Neovasc Company Profile
Neovasc Inc (Neovasc) is a specialty medical device company. The Company develops, manufactures and markets products for the cardiovascular marketplace. The Company’s segment is the development, manufacture and marketing of medical devices. Its products include the Tiara technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer for the treatment of refractory angina, and tissue products.
Read More
- Five stocks we like better than Neovasc
- What is a Low P/E Ratio and What Does it Tell Investors?
- Analysts Predict New Highs for Cybersecurity Stock by Christmas
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Nuclear Power Reaches Critical Mass: Top Stocks to Watch Now
- What are earnings reports?
- 2 Energy Stocks Surging on Billion-Dollar DOE Loan Commitments
Receive News & Ratings for Neovasc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neovasc and related companies with MarketBeat.com's FREE daily email newsletter.
